Minoru Yonezawa

491 total citations
16 papers, 400 citations indexed

About

Minoru Yonezawa is a scholar working on Molecular Medicine, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Minoru Yonezawa has authored 16 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Medicine, 7 papers in Infectious Diseases and 7 papers in Molecular Biology. Recurrent topics in Minoru Yonezawa's work include Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Cancer therapeutics and mechanisms (5 papers). Minoru Yonezawa is often cited by papers focused on Antibiotic Resistance in Bacteria (9 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Cancer therapeutics and mechanisms (5 papers). Minoru Yonezawa collaborates with scholars based in Japan. Minoru Yonezawa's co-authors include Yasuo Watanabe, Hirokazu Narita, Masahiro Takahata, Junichi Mitsuyama, Shinzaburo Minami, Yozo Todo, Takashi Ida, Eiki Shitara, Takahisa Suzuki and Midori Ishikawa and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Cellular Physiology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Minoru Yonezawa

16 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Minoru Yonezawa Japan 10 181 164 139 123 120 16 400
N. Moreau France 8 284 1.6× 192 1.2× 174 1.3× 120 1.0× 89 0.7× 11 449
M. Michéa-Hamzehpour Switzerland 10 335 1.9× 216 1.3× 214 1.5× 106 0.9× 74 0.6× 18 554
Kristen N. Schurek Canada 10 251 1.4× 148 0.9× 183 1.3× 142 1.2× 50 0.4× 10 457
A J Godfrey Canada 14 232 1.3× 126 0.8× 186 1.3× 91 0.7× 52 0.4× 17 443
M P Draper United States 6 90 0.5× 123 0.8× 202 1.5× 92 0.7× 82 0.7× 7 544
K Katsu Japan 8 146 0.8× 110 0.7× 87 0.6× 135 1.1× 170 1.4× 11 397
P. B. Harper United Kingdom 9 247 1.4× 195 1.2× 81 0.6× 104 0.8× 36 0.3× 17 377
H. MUNAYYER United States 9 194 1.1× 72 0.4× 128 0.9× 82 0.7× 120 1.0× 13 381
Megumi Kono Japan 14 174 1.0× 85 0.5× 349 2.5× 61 0.5× 229 1.9× 48 606
Ingrid Heinze‐Krauss Switzerland 5 177 1.0× 178 1.1× 59 0.4× 81 0.7× 215 1.8× 5 380

Countries citing papers authored by Minoru Yonezawa

Since Specialization
Citations

This map shows the geographic impact of Minoru Yonezawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minoru Yonezawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minoru Yonezawa more than expected).

Fields of papers citing papers by Minoru Yonezawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minoru Yonezawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minoru Yonezawa. The network helps show where Minoru Yonezawa may publish in the future.

Co-authorship network of co-authors of Minoru Yonezawa

This figure shows the co-authorship network connecting the top 25 collaborators of Minoru Yonezawa. A scholar is included among the top collaborators of Minoru Yonezawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minoru Yonezawa. Minoru Yonezawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jin, Wanchun, Jun‐ichi Wachino, Yoshihiro Yamaguchi, et al.. (2017). Structural Insights into the TLA-3 Extended-Spectrum β-Lactamase and Its Inhibition by Avibactam and OP0595. Antimicrobial Agents and Chemotherapy. 61(10). 12 indexed citations
2.
Takahata, Sho, Yukari Tanaka, Keiko Yamada, et al.. (2005). Therapeutic Effect of ME1036 on Endocarditis Experimentally Induced by Methicillin-Resistant Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 49(8). 3526–3528. 4 indexed citations
3.
Ida, Takashi, Takahisa Suzuki, Takayoshi Fukushima, et al.. (2005). Comparison of activities of β-lactam antibiotics against Streptococcus pneumoniae with recombinant penicillin-binding protein genes from a penicillin-resistant strain. Journal of Infection and Chemotherapy. 11(2). 107–111. 3 indexed citations
4.
Ida, Takashi, Midori Ishikawa, Yumi Osaki, et al.. (2004). Complete Sequences of Six Penicillin-Binding Protein Genes from 40 Streptococcus pneumoniae Clinical Isolates Collected in Japan. Antimicrobial Agents and Chemotherapy. 48(6). 2244–2250. 51 indexed citations
5.
Ida, Takashi, et al.. (2004). In Vitro Activities of ME1036 (CP5609), a Novel Parenteral Carbapenem, against Methicillin-Resistant Staphylococci. Antimicrobial Agents and Chemotherapy. 48(8). 2831–2837. 36 indexed citations
6.
Hori, Ritsuko, et al.. (2000). Therapeutic effects of parenteral β-lactam antibiotics on experimental otitis media caused by penicillin-resistant Streptococcus pneumoniae in guinea-pigs. Journal of Antimicrobial Chemotherapy. 45(3). 311–314. 6 indexed citations
7.
Yonezawa, Minoru, et al.. (2000). A new model of pulmonary superinfection with Aspergillus fumigatus and Pseudomonas aeruginosa in mice. Journal of Infection and Chemotherapy. 6(3). 155–161. 14 indexed citations
8.
Takahata, Masahiro, Junichi Mitsuyama, Minoru Yonezawa, et al.. (1999). In Vitro and In Vivo Antimicrobial Activities of T-3811ME, a Novel Des-F(6)-Quinolone. Antimicrobial Agents and Chemotherapy. 43(5). 1077–1084. 128 indexed citations
9.
Takahata, Masahiro, et al.. (1996). Mutations in the gyrA and grlA genes of quinolone-resistant clinica isolates of methicillin-resistant Staphylococcus aureus. Journal of Antimicrobial Chemotherapy. 38(3). 543–546. 27 indexed citations
10.
Yonezawa, Minoru, et al.. (1995). Analysis of the NH2‐Terminal 87th Amino Acid of Escherichia coli GyrA in Quinolone‐Resistance. Microbiology and Immunology. 39(7). 517–520. 4 indexed citations
11.
Yonezawa, Minoru, et al.. (1995). DNA gyrase gyrA mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 39(9). 1970–1972. 54 indexed citations
12.
Yonezawa, Minoru, et al.. (1995). Analysis of the NH2‐Terminal 83rd Amino Acid of Escherichia coli GyrA in Quinolone‐Resistance. Microbiology and Immunology. 39(4). 243–247. 20 indexed citations
13.
Yonezawa, Minoru, Junko Suzuki, Makoto Nishiyama, Sueharu Horinouchi, & Teruhiko Beppu. (1993). Role of the amino-terminal amino acid sequences determining the in vitro refolding process of prochymosin polypeptide. Journal of Biotechnology. 28(1). 85–97. 8 indexed citations
14.
Sato, Seiji, Hiroaki Yamamoto, Minoru Yonezawa, & Takuji Takeuchi. (1984). Serum and substratum‐dependent coupled loss of differentiated and tumorigenic phenotypes in B16‐conv melanoma cells. Journal of Cellular Physiology. 121(1). 74–80. 4 indexed citations
15.
Tsuchiya, Takeshi, et al.. (1958). Serological classification of the genus Saccharomyces.. PubMed. 9(6). 359–70. 18 indexed citations
16.
Tsuchiya, Takeshi, et al.. (1957). Serological classification of the genus Rhodotorula.. PubMed. 8(4). 215–24. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026